These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29564400)

  • 1. Heterogeneous Antimicrobial Susceptibility Characteristics in
    Qin X; Zhou C; Zerr DM; Adler A; Addetia A; Yuan S; Greninger AL
    mSphere; 2018; 3(2):. PubMed ID: 29564400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
    Qin X; Zerr DM; McNutt MA; Berry JE; Burns JL; Kapur RP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5971-81. PubMed ID: 22964251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
    Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
    Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
    Rojas LJ; Yasmin M; Benjamino J; Marshall SM; DeRonde KJ; Krishnan NP; Perez F; Colin AA; Cardenas M; Martinez O; Pérez-Cardona A; Rhoads DD; Jacobs MR; LiPuma JJ; Konstan MW; Vila AJ; Smania A; Mack AR; Scott JG; Adams MD; Abbo LM; Bonomo RA
    PLoS One; 2022; 17(3):e0265129. PubMed ID: 35358221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
    Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
    Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome features and antibiotic resistance of Pseudomonas aeruginosa strains isolated in patients with cystic fibrosis in the Russian Federation.
    Bocharova YA; Savinova TA; Lyamin AV; Kondratenko OV; Polikarpova SV; Zhilina SV; Fedorova NI; Semykin SY; Chaplin AV; Korostin DO; Mayansky NA; Chebotar IV
    Klin Lab Diagn; 2021 Oct; 66(10):629-634. PubMed ID: 34665950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and impact of oprD mutations in Pseudomonas aeruginosa strains in cystic fibrosis.
    Sherrard LJ; Wee BA; Duplancic C; Ramsay KA; Dave KA; Ballard E; Wainwright CE; Grimwood K; Sidjabat HE; Whiley DM; Beatson SA; Kidd TJ; Bell SC
    J Cyst Fibros; 2022 Jan; 21(1):e35-e43. PubMed ID: 33775602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of
    Vanderwoude J; Azimi S; Read TD; Diggle SP
    mBio; 2024 Feb; 15(2):e0310923. PubMed ID: 38171021
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence and Microevolution of
    Bianconi I; D'Arcangelo S; Esposito A; Benedet M; Piffer E; Dinnella G; Gualdi P; Schinella M; Baldo E; Donati C; Jousson O
    Front Microbiol; 2018; 9():3242. PubMed ID: 30692969
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.
    Fricks-Lima J; Hendrickson CM; Allgaier M; Zhuo H; Wiener-Kronish JP; Lynch SV; Yang K
    Int J Antimicrob Agents; 2011 Apr; 37(4):309-15. PubMed ID: 21382698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.
    Marvig RL; Dolce D; Sommer LM; Petersen B; Ciofu O; Campana S; Molin S; Taccetti G; Johansen HK
    BMC Microbiol; 2015 Oct; 15():218. PubMed ID: 26482905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution.
    Qin X
    Crit Rev Microbiol; 2016; 42(1):144-57. PubMed ID: 24766052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.
    AbdulWahab A; Taj-Aldeen SJ; Ibrahim E; Abdulla SH; Muhammed R; Ahmed I; Abdeen Y; Sadek O; Abu-Madi M
    Infect Drug Resist; 2014; 7():309-16. PubMed ID: 25429232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
    Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.